|
The value of genetic testing for type 2B Von Willebrand disease.
Clin Lab Haematol. 2006 Feb; 28(1):17-21.
Roland K, Rapson D, Lillicrap D, James P. |
|
Antiphospholipid syndrome in patients with retinal venous occlusion.
Thromb Res. 2006 Ene; 117(4):365-9.
Paccalin M, Manic H, Bouche G, Landron C, Mercie M, Boinot C, Gombert JM, Roblot P, Dighiero P. |
|
Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective.
Crit Care. 2006 Ene; 10(4):R120-.
Vincent JL, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR. |
|
Mechanisms of cancer-induced thrombosis in cancer.
Pathophysiol Haemost Thromb. 2006 Ene; 35(1-2):103-10.
Rickles FR. |
|
Mechanisms of cancer-induced thrombosis in cancer.
Pathophysiol Haemost Thromb. 2006 Ene; 35(1-2):103-10.
Rickles FR. |
|
Contribution of the -455G/A polymorphism at beta-fibrinogen gene and of the Leiden mutation to hemorheological parameters in ischemic stroke patients.
Clin Hemorheol Microcirc. 2006 Ene; 31(1-2):75-82.
Pongracz E, Andrikovics H, Csornai M, Bernat IS, Nagy Z. |
|
Antiphospholipid syndrome: an overview.
Clin Lab Sci. 2006 Ene; 19(3):144-7.
Black A. |
|
Anticoagulation in ischemic stroke: opportunities in arterial disease.
Cerebrovasc Dis. 2005 Dic; 20 Suppl 2:101-8.
van Gijn J, Algra A. |
|
The Antithrombotic Effect of Melagatran in Combination With Clopidogrel and/or Aspirin (carotid artery primary thrombosis study).
J Cardiovasc Pharmacol. 2005 Oct; 46(4):526-33.
Hong TT, Huang J, Driscoll E, Lucchesi BR. |
|
Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics.
Mol Genet Metab. 2005 Oct; 86(1-2):91-9. Epub 2005 Sep 26 Dic
Bauduer F, Lacombe D. |
|
The importance of the protein C system in the pathogenesis of venous thrombosis.
Hematology. 2005 Oct; 10(1):138-9.
Dahlback B. |
|
Hypercoagulable States.
Hematology. 2005 Oct; 10(1):39-.
Bauer K. |
|
More on: intensity of warfarin anticoagulation in APS.
J Thromb Haemost. 2005 Oct; 3(10):2368-9.
Key NS. |
|
Clinical factors and recurrent venous thrombotic events.
JAMA. 2005 Sep; 294(12):1489-90.
Flansbaum B. |
|
Atherothrombosis and high-risk plaque part I: evolving concepts.
J Am Coll Cardiol. 2005 Sep; 46(6):937-54.
Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. |
|
Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems.
J Neurol. 2005 Sep; Epub ahead of print Dic
Lichy C, Dong-Si T, Reuner K, Genius J, Rickmann H, Hampe T, Dolan T, Stoll F, Grau A. |
|
Thromboembolism in Heart Transplantation: Role of Prothrombin G20210A and Factor V Leiden.
Transplantation. 2005 Sep; 80(5):590-594.
Miriuka SG, Langman LJ, Evrovski J, Miner SE, Kozuszko S, D´mello N, Delgado DH, Wong BY, Ross HJ, Cole DE. |
|
Direct thrombin inhibitors.
N Engl J Med. 2005 Sep; 353(10):1028-40.
Di Nisio M, Middeldorp S, Buller HR. |
|
Deep venous thrombosis in patients with acute pulmonary embolism: prevalence, risk factors, and clinical significance.
Chest. 2005 Sep; 128(3):1593-600.
Girard P, Sanchez O, Leroyer C, Musset D, Meyer G, Stern JB, Parent F. |
|
Air travel and thrombosis.
Br J Haematol. 2005 Sep; 130(5):671-80.
Chee YL, Watson HG |
